Kaplan A, El-Samadi L, Zahreddine R, Amin G, Booz G, Zouein F
Acta Physiol (Oxf). 2025; 241(3):e70010.
PMID: 39960030
PMC: 11831727.
DOI: 10.1111/apha.70010.
Inazumi H, Kuwahara K
Biology (Basel). 2022; 11(8).
PMID: 36009824
PMC: 9405064.
DOI: 10.3390/biology11081197.
Rowe G, Tracy E, Beare J, LeBlanc A
Geroscience. 2021; 44(1):329-348.
PMID: 34608562
PMC: 8811091.
DOI: 10.1007/s11357-021-00455-6.
Hammer K, Mustroph J, Stauber T, Birchmeier W, Wagner S, Maier L
PLoS One. 2021; 16(6):e0252649.
PMID: 34086773
PMC: 8177441.
DOI: 10.1371/journal.pone.0252649.
Nubbemeyer B, Pepanian A, George A, Imhof D
ChemMedChem. 2021; 16(11):1696-1715.
PMID: 33615736
PMC: 8252600.
DOI: 10.1002/cmdc.202100039.
GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.
Laudette M, Formoso K, Lezoualch F
Cells. 2021; 10(1).
PMID: 33466800
PMC: 7830799.
DOI: 10.3390/cells10010154.
Functions of PDE3 Isoforms in Cardiac Muscle.
Movsesian M, Ahmad F, Hirsch E
J Cardiovasc Dev Dis. 2018; 5(1).
PMID: 29415428
PMC: 5872358.
DOI: 10.3390/jcdd5010010.
A Computational Approach for Understanding the Interactions between Graphene Oxide and Nucleoside Diphosphate Kinase with Implications for Heart Failure.
Ray A, Macwan I, Singh S, Silwal S, Patra P
Nanomaterials (Basel). 2018; 8(2).
PMID: 29360759
PMC: 5853690.
DOI: 10.3390/nano8020057.
Biventricular differences in β-adrenergic receptor signaling following burn injury.
Guillory A, Clayton R, Prasai A, El Ayadi A, Herndon D, Finnerty C
PLoS One. 2017; 12(12):e0189527.
PMID: 29232706
PMC: 5726759.
DOI: 10.1371/journal.pone.0189527.
Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update.
Abu-Taha I, Heijman J, Feng Y, Vettel C, Dobrev D, Wieland T
Lab Invest. 2017; 98(2):190-197.
PMID: 29035382
DOI: 10.1038/labinvest.2017.103.
G protein-coupled receptors in cardiac biology: old and new receptors.
Foster S, Roura E, Molenaar P, Thomas W
Biophys Rev. 2017; 7(1):77-89.
PMID: 28509979
PMC: 5418426.
DOI: 10.1007/s12551-014-0154-2.
Beta blockers in heart failure haemodynamics, clinical effects and modes of action.
de Milliano P, Tijssen J, van Zwieten P, Lie K
Neth Heart J. 2015; 9(8):334-342.
PMID: 25696756
PMC: 2499649.
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T, Mummery C, Knollmann B
Cardiovasc Res. 2015; 105(4):424-38.
PMID: 25618410
PMC: 4349163.
DOI: 10.1093/cvr/cvv017.
Non-classical regulation of β1- and β 2-adrenoceptor-mediated inotropic responses in rat heart ventricle by the G protein Gi.
Bull Melsom C, Hussain R, Orstavik O, Aronsen J, Sjaastad I, Skomedal T
Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(12):1177-86.
PMID: 25216690
DOI: 10.1007/s00210-014-1036-7.
Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium.
Molenaar P, Christ T, Berk E, Engel A, Gillette K, Galindo-Tovar A
Naunyn Schmiedebergs Arch Pharmacol. 2014; 387(7):629-40.
PMID: 24668024
DOI: 10.1007/s00210-014-0974-4.
Gap junction modulation and its implications for heart function.
Kurtenbach S, Kurtenbach S, Zoidl G
Front Physiol. 2014; 5:82.
PMID: 24578694
PMC: 3936571.
DOI: 10.3389/fphys.2014.00082.
Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.
Li-Sha G, Yi-He C, Na-Dan Z, Teng Z, Yue-Chun L
BMC Cardiovasc Disord. 2013; 13:100.
PMID: 24225056
PMC: 3840656.
DOI: 10.1186/1471-2261-13-100.
Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.
Fajardo G, Zhao M, Urashima T, Farahani S, Hu D, Reddy S
J Mol Cell Cardiol. 2013; 63:155-64.
PMID: 23920331
PMC: 3791213.
DOI: 10.1016/j.yjmcc.2013.07.016.
PDE4 in the human heart - major player or little helper?.
Eschenhagen T
Br J Pharmacol. 2013; 169(3):524-7.
PMID: 23489196
PMC: 3682701.
DOI: 10.1111/bph.12168.
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
Molenaar P, Christ T, Hussain R, Engel A, Berk E, Gillette K
Br J Pharmacol. 2013; 169(3):528-38.
PMID: 23489141
PMC: 3682702.
DOI: 10.1111/bph.12167.